Stockreport

Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy [Yahoo! Finance]

ASAHI KAISEI CRP UNSP/ADR  (AHKSY) 
NASDAQ:AMEX Investor Relations: asahi-kasei.co.jp/asahi/en/ir
PDF Aicuris revenue expected to reach $500 million by 2030 FDA has granted Priority Review for the pritelivir New Drug Application. Prescription Drug User Fee Act (PDUFA) [Read more]